Gossamer Bio, Inc. (GOSS)

Gossamer Bio Statistics

Total Valuation

Gossamer Bio has a market cap or net worth of $217.97 million. The enterprise value is $94.56 million.

Market Cap	217.97M
Enterprise Value	94.56M

Important Dates

The next estimated earnings date is Tuesday, March 4, 2025, before market open.

Earnings Date	Mar 4, 2025
Ex-Dividend Date	n/a

Share Statistics

Gossamer Bio has 226.60 million shares outstanding. The number of shares has increased by 88.97% in one year.

Current Share Class	226.60M
Shares Outstanding	226.60M
Shares Change (YoY)	+88.97%
Shares Change (QoQ)	-5.11%
Owned by Insiders (%)	3.14%
Owned by Institutions (%)	63.73%
Float	188.12M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.07
Forward PS	12.20
PB Ratio	4.03
P/TBV Ratio	4.03
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.90
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.74, with a Debt / Equity ratio of 3.76.

Current Ratio	6.74
Quick Ratio	6.53
Debt / Equity	3.76
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.23

Financial Efficiency

Return on equity (ROE) is -90.26% and return on invested capital (ROIC) is -13.58%.

Return on Equity (ROE)	-90.26%
Return on Assets (ROA)	-11.24%
Return on Capital (ROIC)	-13.58%
Revenue Per Employee	$780,163
Profits Per Employee	-$530,719
Employee Count	135
Asset Turnover	0.30
Inventory Turnover	n/a

Taxes

In the past 12 months, Gossamer Bio has paid $3.30 million in taxes.

Income Tax	3.30M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +3.09% in the last 52 weeks. The beta is 1.81, so Gossamer Bio's price volatility has been higher than the market average.

Beta (5Y)	1.81
52-Week Price Change	+3.09%
50-Day Moving Average	0.84
200-Day Moving Average	0.86
Relative Strength Index (RSI)	54.24
Average Volume (20 Days)	1,040,121

Short Selling Information

The latest short interest is 6.12 million, so 2.70% of the outstanding shares have been sold short.

Short Interest	6.12M
Short Previous Month	7.02M
Short % of Shares Out	2.70%
Short % of Float	3.25%
Short Ratio (days to cover)	2.93

Income Statement

In the last 12 months, Gossamer Bio had revenue of $105.32 million and -$71.65 million in losses. Loss per share was -$0.32.

Revenue	105.32M
Gross Profit	105.32M
Operating Income	-62.82M
Pretax Income	-172.58M
Net Income	-71.65M
EBITDA	-61.80M
EBIT	-62.82M
Loss Per Share	-$0.32

Balance Sheet

The company has $327.03 million in cash and $203.63 million in debt, giving a net cash position of $123.41 million or $0.54 per share.

Cash & Cash Equivalents	327.03M
Total Debt	203.63M
Net Cash	123.41M
Net Cash Per Share	$0.54
Equity (Book Value)	54.14M
Book Value Per Share	0.24
Working Capital	293.18M

Cash Flow

Operating Cash Flow	-1.41M
Capital Expenditures	n/a
Free Cash Flow	-1.41M
FCF Per Share	-$0.01

Margins

Gross margin is 100.00%, with operating and profit margins of -59.64% and -68.03%.

Gross Margin	100.00%
Operating Margin	-59.64%
Pretax Margin	-64.89%
Profit Margin	-68.03%
EBITDA Margin	-58.68%
EBIT Margin	-59.64%
FCF Margin	n/a

Dividends & Yields

Gossamer Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-88.97%
Shareholder Yield	-88.97%
Earnings Yield	-32.87%
FCF Yield	-0.65%

Analyst Forecast

The average price target for Gossamer Bio is $9.20, which is 856.44% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.20
Price Target Difference	856.44%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Gossamer Bio has an Altman Z-Score of -3.81 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.81
Piotroski F-Score	2